UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 755

Sortiert nach

Epidemiology of prostate cancer in Asian countries

International journal of urology, 2018-06, Vol.25 (6), p.524-531

2018

Volltextzugriff (PDF)

Extracellular vesicles as biomarkers and therapeutic targets for cancer

American Journal of Physiology: Cell Physiology, 2020-01, Vol.318 (1), p.C29-C39

2020

Volltextzugriff (PDF)

Circulating miRNA panels for specific and early detection in bladder cancer

Cancer science, 2019-01, Vol.110 (1), p.408-419

2019

Volltextzugriff (PDF)

Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

International journal of clinical oncology, 2020-11, Vol.25 (11), p.1892-1900

2020

Volltextzugriff (PDF)

Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care

Asian journal of surgery, 2020-10, Vol.43 (10), p.967-972

2020

Volltextzugriff (PDF)

Contrasting altitudinal patterns of diversity between bumblebees and bumblebee‐visited flowers: Poverty of bumblebee diversity in a high mountain of Japan

Ecological research, 2020-05, Vol.35 (3), p.504-510

2020

Volltextzugriff (PDF)

Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis

International journal of clinical oncology, 2020-02, Vol.25 (2), p.247-257

2020

Volltextzugriff (PDF)

Global Trends of Latent Prostate Cancer in Autopsy Studies

Cancers, 2021-01, Vol.13 (2), p.359

2021

Volltextzugriff (PDF)

Effects of human Muse cells on bladder inflammation, overactivity, and nociception in a chemically induced Hunner-type interstitial cystitis-like rat model

International Urogynecology Journal, 2022-05, Vol.33 (5), p.1293-1301

2022

Volltextzugriff (PDF)

Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

Clinical cancer research, 2019-05, Vol.25 (10), p.3016-3025

2019

Volltextzugriff (PDF)

Extracellular vesicles: Toward a clinical application in urological cancer treatment

International journal of urology, 2018-06, Vol.25 (6), p.533-543

2018

Volltextzugriff (PDF)

Comparison of perioperative complications and health‐related quality of life between robot‐assisted and open radical cystectomy: A systematic review and meta‐analysis

International journal of urology, 2019-08, Vol.26 (8), p.760-774

2019

Volltextzugriff (PDF)

Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis

BJU international, 2022-04, Vol.129 (4), p.423-433

2022

Volltextzugriff (PDF)

The miR‐1908/SRM regulatory axis contributes to extracellular vesicle secretion in prostate cancer

Cancer science, 2020-09, Vol.111 (9), p.3258-3267

2020

Volltextzugriff (PDF)

Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis

Cancer Immunology, Immunotherapy, 2021-02, Vol.70 (2), p.265-273

2021

Volltextzugriff (PDF)

Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men

JNCI : Journal of the National Cancer Institute, 2013-07, Vol.105 (14), p.1050-1058

2013

Volltextzugriff (PDF)

Impact of family history on oncological outcomes in primary therapy for localized prostate cancer patients: a systematic review and meta-analysis

Prostate cancer and prostatic diseases, 2021-09, Vol.24 (3), p.638-646

2021

Volltextzugriff (PDF)

Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis

International journal of clinical oncology, 2020-08, Vol.25 (8), p.1459-1474

2020

Volltextzugriff (PDF)

First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

European urology oncology, 2021-10, Vol.4 (5), p.755-765

2021

Volltextzugriff (PDF)

The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy

International journal of clinical oncology, 2022-02, Vol.27 (2), p.396-402

2022

Volltextzugriff (PDF)

Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis

International journal of clinical oncology, 2022-01, Vol.27 (1), p.59-71

2022

Volltextzugriff (PDF)

Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis

Prostate cancer and prostatic diseases, 2020-12, Vol.23 (4), p.539-548

2020

Volltextzugriff (PDF)

Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study

International journal of clinical oncology, 2022-01, Vol.27 (1), p.194-201

2022

Volltextzugriff (PDF)

ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer?

Annals of surgical oncology, 2021-12, Vol.28 (13), p.9188-9189

2021

Volltextzugriff (PDF)

How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?

International journal of clinical oncology, 2022, Vol.27 (1), p.184-193

2022

Volltextzugriff (PDF)

1 – 25 von 755

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(579)
Mit Volltextzugriff
(631)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Epidemiology of prostate cancer in Asian countries

Extracellular vesicles as biomarkers and therapeutic targets for cancer

Circulating miRNA panels for specific and early detection in bladder cancer

Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care

Contrasting altitudinal patterns of diversity between bumblebees and bumblebee‐visited flowers: Poverty of bumblebee diversity in a high mountain of Japan

Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis

Global Trends of Latent Prostate Cancer in Autopsy Studies

Effects of human Muse cells on bladder inflammation, overactivity, and nociception in a chemically induced Hunner-type interstitial cystitis-like rat model

Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

Extracellular vesicles: Toward a clinical application in urological cancer treatment

Comparison of perioperative complications and health‐related quality of life between robot‐assisted and open radical cystectomy: A systematic review and meta‐analysis

Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis

The miR‐1908/SRM regulatory axis contributes to extracellular vesicle secretion in prostate cancer

Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis

Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men

Impact of family history on oncological outcomes in primary therapy for localized prostate cancer patients: a systematic review and meta-analysis

Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis

First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy

Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis

Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis

Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study

ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer?

How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?

Suchergebnisse filtern